Skip to main content

InMed Pharmaceuticals, Inc. (INM)

NASDAQ: INM · IEX Real-Time Price · USD
1.63 0.01 (0.62%)
Oct 25, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is July - June.
Year202120202019
Selling, General & Admin
4.483.234.3
Research & Development
5.345.815.13
Other Operating Expenses
0.120.110.12
Operating Expenses
9.949.159.54
Operating Income
-9.94-9.15-9.54
Interest Expense / Income
0.3600
Other Expense / Income
-0.1-0.21-0.29
Pretax Income
-10.2-8.94-9.25
Net Income
-10.2-8.94-9.25
Net Income Common
-10.2-8.94-9.25
Shares Outstanding (Basic)
755
Shares Outstanding (Diluted)
755
Shares Change
28.71%0.55%-
EPS (Basic)
-1.52-1.71-1.78
EPS (Diluted)
-1.52-1.71-1.78
Free Cash Flow Per Share
-1.46-1.42-1.28
EBITDA
-9.61-8.74-9.13
EBIT
-9.84-8.94-9.25
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).